# Repligen acquires Spectrum LifeSciences for $359 million

Repligen Corp acquired Spectrum, Inc. (Spectrum LifeSciences), a maker of hollow-fiber filtration products and KrosFlo TFF systems, for approximately $359 million ($120 million cash plus $239 million in Repligen stock). The deal closed on August 1, 2017.

- Type: Acquisition
- Announced: 2017-08-01
- Where: Rancho Dominguez, California, USA, United States
- Value: $359.0M
- Status: completed
- Products: hollow-fiber filtration products, KrosFlo TFF systems, Spectra/Por dialysis products
- Sectors: [Industrial Machinery](https://endata.com/sectors/industrial-machinery.md)

## Companies

- [Repligen](https://endata.com/companies/25982.md) (acquirer)
- [Spectrum LifeSciences](https://endata.com/companies/25983.md) (target)

## Sources

- [vectorshift.ai](https://vectorshift.ai/research/deals/repligen-spectrum-spectrum-lifesciences-2017), 2017-08-01: "This is a pivotal transaction for Repligen that meets all of our acquisition criteria and is a major step forward in building Repligen as a global leader in bioprocessing."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.